Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sanae Bouali"'
Autor:
Gioia Mione, Lisa Humbertjean, Nicolas Girerd, Candice Sabben, Arif Karakus, Jean-Charles Sanchez, Anthony Wietrich, Karine Lavandier, Sophie Marchal, Anne Aubertin, Sanae Bouali, Kevin Duarte, Sandrine Reymond
Publikováno v:
BMJ Open, Vol 11, Iss 8 (2021)
Introduction Plasma biomarkers may be useful in diagnosing acute cerebral infarction requiring urgent reperfusion, but their performance remains to be confirmed. If confirmed, these molecules could be used to develop rapid and reliable decentralised
Externí odkaz:
https://doaj.org/article/45ea611dfc784f92b3d6d6b9ddea1f8b
Autor:
Benjamin Gory, Jean-Charles Sanchez, Sanae Bouali, Anne Aubertin, Gioia Mione, Lisa Humbertjean, Nicolas Girerd, Anthony Wietrich, Karine Lavandier, Candice Sabben, Sophie Marchal, Sébastien Richard, Kevin Duarte, Sandrine Reymond, Arif Karakus
Publikováno v:
BMJ Open
BMJ Open, BMJ Publishing Group, 2021, 11 (8), pp.e046167. ⟨10.1136/bmjopen-2020-046167⟩
BMJ Open, Vol 11, Iss 8 (2021)
BMJ Open, BMJ Publishing Group, 2021, 11 (8), pp.e046167. ⟨10.1136/bmjopen-2020-046167⟩
BMJ Open, Vol 11, Iss 8 (2021)
IntroductionPlasma biomarkers may be useful in diagnosing acute cerebral infarction requiring urgent reperfusion, but their performance remains to be confirmed. If confirmed, these molecules could be used to develop rapid and reliable decentralised m
Autor:
Jean-Marc Boivin, Céline Leroy, Elise Eby, Anne Pizard, Zohra Lamiral, Sanae Bouali, Erwan Bozec, Ludovic Mercklé, Patrick Rossignol, Jean-Loup Machu, João Pedro Ferreira, Nicolas Girerd, Faiez Zannad
Publikováno v:
International journal of epidemiology. 47(2)
Publikováno v:
Technology in cancer researchtreatment. 8(6)
The development of new vectors to deliver DNA into cells for therapy of cancers or genetic diseases has been a major area of research for many years. However, the clinical application of this technology requires the development of efficient, reliable
Autor:
Anne-Sophie Chretien, Sophie Marchal, T. Galenne, Sanae Bouali, Carole Ramacci, Marie Rouyer, Philippe Juin, Philippe Becuwe, Jean-Louis Merlin
Publikováno v:
Cancer Gene Therapy
Cancer Gene Therapy, Nature Publishing Group, 2009, 16 (6), pp.498-507. ⟨10.1038/cgt.2008.100⟩
Cancer Gene Therapy, Nature Publishing Group, 2009, 16 (6), pp.498-507. ⟨10.1038/cgt.2008.100⟩
International audience; Cetuximab (Erbitux) is an anti-epidermal growth factor receptor (EGFR) monoclonal antibody whose activity is related to the inhibition of EGFR downstream signaling pathways. P53 and phosphatase and tensin homologue deleted on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::032711218ed30cd2e19a1733f72d5335
https://hal.archives-ouvertes.fr/hal-00372449
https://hal.archives-ouvertes.fr/hal-00372449
Autor:
Pascal Genin, Carole Ramacci, Thierry Bastogne, Agnès Leroux, Jean-Louis Merlin, Anne-Sophie Chretien, Fadila Chergui, Sanae Bouali, Marie Rouyer
Publikováno v:
Clinical chemistry. 55(7)
Background: Human epidermal growth factor receptor (HER) downstream signaling kinases have important effects on tumor response to anti-HER monoclonal antibodies and tyrosine kinase inhibitors. We validated an assay that uses phosphoprotein arrays for
Autor:
Anne-Sophie Chretien, Philippe Becuwe, Sanae Bouali, Jean-Louis Merlin, Carole Ramacci, Marie Rouyer
Publikováno v:
Oncology Reports.
Overexpression of epidermal growth factor receptor (EGFR) and mutation of pten tumor suppressor gene in human cancer cells leads to activated EGFR downstream signaling including PI3-kinase/AKT (PI3K/AKT) and/or mitogen-activated protein kinases (RAS/
Autor:
Thierry Bastogne, C. Ramacci, F. Chergui, Sanae Bouali, A. Leroux, Jean-Louis Merlin, Marie Rouyer, Anne-Sophie Chretien, P. Genin
Publikováno v:
European Journal of Cancer Supplements
20th Meeting of the European Association for Cancer Research
20th Meeting of the European Association for Cancer Research, Jul 2008, Lyon, France. pp.96, ⟨10.1016/S1359-6349(08)71545-3⟩
20th Meeting of the European Association for Cancer Research
20th Meeting of the European Association for Cancer Research, Jul 2008, Lyon, France. pp.96, ⟨10.1016/S1359-6349(08)71545-3⟩
International audience; Background: human epidermal growth factor receptors (HER) downstream signalling kinases have major consequences on tumor response to anti- HER monoclonal antibodies and tyrosine kinase inhibitors targeted therapy. The present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2279cab39f2d803559e34ba13ea808cc
https://hal.archives-ouvertes.fr/hal-00344656
https://hal.archives-ouvertes.fr/hal-00344656
Autor:
Jean-Paul Behr, Alioune Ndoye, François Guillemin, Gilles Dolivet, Jean-Louis Merlin, Patrick Erbacher, Sanae Bouali, Agnès Leroux, Kristian Berg
Publikováno v:
International journal of oncology. 25(6)
p53 is frequently mutated in head-and-neck squamous cell carcinoma. Wild-type p53 gene transfer induces apoptosis in vitro and tumor regression in vivo and clinical investigations of p53 gene therapy have been reported, mostly using viral vectors. No
Autor:
C. Ramacci, Anne-Sophie Chretien, Sophie Marchal, T. Galenne, Sanae Bouali, Marie Rouyer, Jean-Louis Merlin, Philippe Juin, Philippe Becuwe
Publikováno v:
European Journal of Cancer Supplements. 6:146